Evidence map›Paper›PMID 34538422›Full record

ArticleBiological psychiatry2021

Hyperexcitable Phenotypes in Induced Pluripotent Stem Cell-Derived Neurons From Patients With 15q11-q13 Duplication Syndrome, a Genetic Form of Autism.

James J Fink, Jeremy D Schreiner, Judy E Bloom, Jadin James, Dylan S Baker, Tiwanna M Robinson, Richard Lieberman, Leslie M Loew, Stormy J Chamberlain, Eric S Levine

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Distinct Synaptic Mechanisms DrivebioRxiv : the preprint server for biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

James J FinkDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington, Connecticut.
Jeremy D SchreinerDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington, Connecticut.
Judy E BloomR.D. Berlin Center for Cell Analysis and Modeling, University of Connecticut School of Medicine, Farmington, Connecticut.
Jadin JamesDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington, Connecticut.
Dylan S BakerDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington, Connecticut.
Tiwanna M RobinsonDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington, Connecticut.
Richard LiebermanDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington, Connecticut.
Leslie M LoewR.D. Berlin Center for Cell Analysis and Modeling, University of Connecticut School of Medicine, Farmington, Connecticut.
Stormy J ChamberlainDepartment of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, Connecticut.
Eric S LevineDepartment of Neuroscience, University of Connecticut School of Medicine, Farmington, Connecticut. Electronic address: eslevine@uchc.edu.
University of Connecticut · US

Funding

Regulation of synaptic plasticity by BDNF-endocannabinoid interactionsR01NS111986 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LEVINE, ERIC S · 2020 to 2025
$2.6M
BDNF-Endocannabinoid Interactions in the Cerebral CortexR01MH094896 · NIMH · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LEVINE, ERIC S · 2012 to 2016
$1.9M
Using genetics to uncover cellular phenotypes underlying Dup15q syndromeR21NS111965 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI CHAMBERLAIN, STORMY JO, LEVINE, ERIC S · 2019 to 2019
$451k
Synaptic signaling in a human stem cell model of Angelman syndromeR21NS078753 · NINDS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI LEVINE, ERIC S · 2012 to 2013
$415k
NIMH NIH HHS R01 MH094896NINDS NIH HHS R01 NS111986NINDS NIH HHS R21 NS078753NINDS NIH HHS R21 NS111965
6 · The paper itself

Abstract

backgroundChromosome 15q11-q13 duplication syndrome (Dup15q) is a neurogenetic disorder caused by duplications of the maternal copy of this region. In addition to hypotonia, motor deficits, and language impairments, patients with Dup15q commonly meet the criteria for autism spectrum disorder and have a high prevalence of seizures. It is known from mouse models that synaptic impairments are a strong component of Dup15q pathophysiology; however, cellular phenotypes that relate to seizures are less clear. The development of patient-derived induced pluripotent stem cells provides a unique opportunity to study human neurons with the exact genetic disruptions that cause Dup15q.

methodsHere, we explored electrophysiological phenotypes in induced pluripotent stem cell-derived neurons from 4 patients with Dup15q compared with 6 unaffected control subjects, 1 patient with a 15q11-q13 paternal duplication, and 3 patients with Angelman syndrome.

resultsWe identified several properties of Dup15q neurons that could contribute to neuronal hyperexcitability and seizure susceptibility. Compared with control neurons, Dup15q neurons had increased excitatory synaptic event frequency and amplitude, increased density of dendritic protrusions, increased action potential firing, and decreased inhibitory synaptic transmission. Dup15q neurons also showed impairments in activity-dependent synaptic plasticity and homeostatic synaptic scaling. Finally, Dup15q neurons showed an increased frequency of spontaneous action potential firing compared with control neurons, in part due to disruption of KCNQ2 potassium channels.

conclusionsTogether, these data point to multiple electrophysiological mechanisms of hyperexcitability that may provide new targets for the treatment of seizures and other phenotypes associated with Dup15q.

Indexed as

Autism Spectrum DisorderAutistic DisorderInduced Pluripotent Stem CellsAnimalsHumansMiceNeuronsPhenotypeAutismAutism spectrum disorderChromosome 15Dup15q syndromeElectrophysiologyHyperexcitabilityiPSCNeurodevelopment

Identifiers

PMID34538422
PMCPMC8571044
OpenAlexW3185145847

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.